Clinical Outcomes of Extreme Lateral Interbody Fusion in the Treatment of Adult Degenerative Scoliosis

Adam M. Caputo; Keith W. Michael; Todd M. Chapman; Gene M. Massey; Cameron R. Howes; Robert E. Isaacs; Christopher R. Brown

doi:10.1100/2012/680643

Back

Clinical Outcomes of Extreme Lateral Interbody Fusion in the Treatment of Adult Degenerative Scoliosis

Journal article

Open access

Peer reviewed

Clinical Outcomes of Extreme Lateral Interbody Fusion in the Treatment of Adult Degenerative Scoliosis

Adam M. Caputo, Keith W. Michael, Todd M. Chapman, Gene M. Massey, Cameron R. Howes, Robert E. Isaacs and Christopher R. Brown

TheScientificWorld, Vol.2012(2012), pp.1-5

01/01/2012

DOI: 10.1100/2012/680643

PMCID: PMC3462377

PMID: 23049476

Files and links (1)

url

https://doi.org/10.1100/2012/680643View

Published (Version of record) Open Access

Abstract

Introduction. The use of extreme lateral interbody fusion (XLIF) and other lateral access surgery is rapidly increasing in popularity. However, limited data is available regarding its use in scoliosis surgery. The objective of this study was to evaluate the clinical outcomes of adults with degenerative lumbar scoliosis treated with XLIF. Methods. Thirty consecutive patients with adult degenerative scoliosis treated by a single surgeon at a major academic institution were followed for an average of 14.3 months. Interbody fusion was completed using the XLIF technique with supplemental posterior instrumentation. Validated clinical outcome scores were obtained on patients preoperatively and at most recent follow-up. Complications were recorded. Results. The study group demonstrated improvement in multiple clinical outcome scores. Oswestry Disability Index scores improved from 24.8 to 19.0 (P < 0.001). Short Form-12 scores improved, although the change was not significant. Visual analog scores for back pain decreased from 6.8 to 4.6 (P < 0.001) while scores for leg pain decreased from 5.4 to 2.8 (P < 0.001). A total of six minor complications (20%) were recorded, and two patients (6.7%) required additional surgery. Conclusions. Based on the significant improvement in validated clinical outcome scores, XLIF is effective in the treatment of adult degenerative scoliosis.

Clinical Study

Details

Title: Subtitle: Clinical Outcomes of Extreme Lateral Interbody Fusion in the Treatment of Adult Degenerative Scoliosis
Creators: Adam M. Caputo - Duke University
Keith W. Michael - Duke University
Todd M. Chapman - Duke University
Gene M. Massey - Duke University
Cameron R. Howes - Duke University
Robert E. Isaacs - Duke Medical Center
Christopher R. Brown - Duke University
Resource Type: Journal article
Publication Details: TheScientificWorld, Vol.2012(2012), pp.1-5
DOI: 10.1100/2012/680643
PMID: 23049476
PMCID: PMC3462377
NLM abbreviation: ScientificWorldJournal
ISSN: 2356-6140
eISSN: 1537-744X
Publisher: The Scientific World Journal
Language: English
Date published: 01/01/2012
Academic Unit: Orthopedics and Rehabilitation
Record Identifier: 9985167644302771

Metrics

1 Record Views

52 Times Cited - Web of Science